WMG cyclists on the HVMC cycle challenge
Donation protected
Staff at WMG are undertaking the High Value Manufacturing Catapult Cycling Challenge on 2nd July to help raise money for our WMG colleague Scott and his family.
Riders will be cycling 145km from Coventry to Sheffield encompassing the WMG and ARMC Catapult centres.
2 brave riders will be completing a 5 day cycle from NCC in Bristol to AFRC in Glasgow- over 800km of riding!
WMG have chosen to show our support to our colleague Scott Crowther and his family, who are raising funds for treatment for their son Ben.
Ben has a rare cancer called Alveolar Rhabdomyosarcoma, first diagnosed in June 2018.
He has received and completed first line, high dose chemotherapy treatment through the NHS in December 2018.
All was looking good as he moved onto low dose 'maintenance' chemo in January 2019. But this treatment did not work. He has relapsed and the cancer has come back.
Ben is now on an experimental clinical trial part funded by Cancer Research UK. His family live in hope but the outlook is bleak. Outcomes for this cancer type has not progressed in 40 years.
There are cases where children with the same disease are doing comparatively well. Ben's family are looking to emulate some of those cases, if possible. This includes complementary supplements and nutrition. Some of these options are are expensive and not available on the NHS, and they may need to travel abroad too.
Funds donated to this page will go directly to support Ben's treatment. Any unused funds will be redirected into research for Rhabdomyosarcoma via our parallel CCLG research fund. We will be transparent in all spending and no penny will be wasted.
Riders will be cycling 145km from Coventry to Sheffield encompassing the WMG and ARMC Catapult centres.
2 brave riders will be completing a 5 day cycle from NCC in Bristol to AFRC in Glasgow- over 800km of riding!
WMG have chosen to show our support to our colleague Scott Crowther and his family, who are raising funds for treatment for their son Ben.
Ben has a rare cancer called Alveolar Rhabdomyosarcoma, first diagnosed in June 2018.
He has received and completed first line, high dose chemotherapy treatment through the NHS in December 2018.
All was looking good as he moved onto low dose 'maintenance' chemo in January 2019. But this treatment did not work. He has relapsed and the cancer has come back.
Ben is now on an experimental clinical trial part funded by Cancer Research UK. His family live in hope but the outlook is bleak. Outcomes for this cancer type has not progressed in 40 years.
There are cases where children with the same disease are doing comparatively well. Ben's family are looking to emulate some of those cases, if possible. This includes complementary supplements and nutrition. Some of these options are are expensive and not available on the NHS, and they may need to travel abroad too.
Funds donated to this page will go directly to support Ben's treatment. Any unused funds will be redirected into research for Rhabdomyosarcoma via our parallel CCLG research fund. We will be transparent in all spending and no penny will be wasted.
Organizer
Sophia Gibbs
Organizer
